InvestorsHub Logo
Followers 252
Posts 28469
Boards Moderated 4
Alias Born 07/07/2004

Re: None

Sunday, 03/22/2020 6:29:15 AM

Sunday, March 22, 2020 6:29:15 AM

Post# of 121
SA: "Danaher's Cepheid gets authorization for quicker Covid-19 test"

* The U.S. Food and Drug Administration issues the first emergency use authorization for a point-of-care Covid-19 diagnostic for the Cepheid Xpert Xpress SARS-CoV 2 test.

* Cepheid is part of Danaher (NYSE:DHR).

* The test will provide results within hours, rather than days like existing tests, said HHS Secretary Alex Azar.

* Cepheid said the test has been designed to operate on any of its more than 23,000 automated GeneXpert Systems worldwide, with a detection time of ~45 minutes.

* The company plans to roll out the new test by March 30, the FDA said, while Cepheid said the test will begin shipping next week." more...

https://seekingalpha.com/news/3554024-danahers-cepheid-gets-authorization-for-quicker-covidminus-19-test


______________________________________________________________
Because the Good Life is Just a Pump or Two Away

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DHR News